DIANTHUS THERAPEUTICS INC
DNTH · NASDAQ
更新於 2026-10-14 10:03:30
$77.58-4.89%
- 今日最高
- $81.46
- 今日最低
- $77.25
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $81.77
- 昨天收盤價
- $81.57
- 成交量
- 853.94K
- 市值
- $4.56B
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-4.14
昨天價格區間
$80.91$83.76
52週價格區間
$32.22$117.87
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 生物科技
- 總部
- 7 TIMES SQUARE, NEW YORK, NY, UNITED STATES, 10036
- 國家
- 美國
- 上市日期
- 2018-06-21
- 財年截止
- 十二月
- 流通股數
- 54.67M
- CIK
- 0001690585
- 官方網址
- dianthustx.com
Dianthus Therapeutics, Inc. 是一家臨床階段的生物技術公司，致力為患有嚴重自身免疫性和炎症性疾病的人群設計、開發和提供新型單克隆抗體。公司總部位於紐約州紐約市。
財務指標
營業收入
2026-06-30
$761K
2026-03-31
$463K
2025-12-31
$284K
2025-09-30
$396K
營業支出
2026-06-30
$62.24M
2026-03-31
$46.92M
2025-12-31
$69.82M
2025-09-30
$40.68M
淨利潤
2026-06-30
-$50.21M
2026-03-31
-$40.83M
2025-12-31
$97.9M
2025-09-30
-$36.76M
淨利潤率
2026-06-30
-6.59K%
2026-03-31
-8.81K%
2025-12-31
34.47K%
2025-09-30
-9.28K%
每股收益
2026-06-30
$-0.90
2026-03-31
$-0.85
2025-12-31
$-1.43
2025-09-30
$-0.97
息稅折舊攤銷前利潤
2026-06-30
-$50.1M
2026-03-31
-$40.75M
2025-12-31
$98M
2025-09-30
-$36.66M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $761K | $463K | $284K | $396K |
| 營業支出 | $62.24M | $46.92M | $69.82M | $40.68M |
| 淨利潤 | -$50.21M | -$40.83M | $97.9M | -$36.76M |
| 淨利潤率 | -6.59K% | -8.81K% | 34.47K% | -9.28K% |
| 每股收益 | $-0.90 | $-0.85 | $-1.43 | $-0.97 |
| 息稅折舊攤銷前利潤 | -$50.1M | -$40.75M | $98M | -$36.66M |
| 有效稅率 | -- | -- | -- | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。